£146.64

Springer Bispecific Antibodies

Name: Bispecific Antibodies
Brand: Springer
Price: 146.64 GBP
Availability: InStock

Immunology

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£147 today · all-time low £144 (Jun 2026) · usually £147

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 79 days · 72 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 79 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £147 (46 days, 63.9%)

Price range: £144 - £147

Price levels: 3 different prices over 72 days

Description

The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy. In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3642432077
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Immunology
Domain: Amazon UK
Release Date: 13 December 2014
Listed Since: 14 December 2014

Barcode

No barcode data available

Springer Bispecific Antibodies

About as cheap as it gets. The only time it was cheaper was 3 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Introduction to Antibody Engineering (Learning Materials in Biosciences)

Antibody Expression and Production: 7 (Cell Engineering, 7)

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Recombinant Antibodies for Immunotherapy

Springer - Immunotherapy of Cancer: An Innovative Treatment

Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases (Progress in Inflammation Research)

Diagnostic and Therapeutic Antibodies: 40 (Methods in Molecular Medicine, 40)

Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)

Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy

Adoptive Immunotherapy: Methods and Protocols: 109 (Methods in Molecular Medicine)

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Antibody-Drug Conjugates: 1045 (Methods in Molecular Biology, 1045)

Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Antibody Engineering Volume 1 (Springer Protocols Handbooks)

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Adverse Events with Biomedicines: Prevention Through Understanding

Regulatory B Cells: Methods and Protocols: 1190 (Methods in Molecular Biology)

Molecular Biology of B Cells